CAS 1187586-58-8

Montelukast EP Impurity E

CAS : 1187586-58-8

Formule : C₄₁H₄₆ClNO₅S₂

Masse moléculaire : 732.39

Ref: 4Z-M-3010

(R,S)-Montelukast Bissulfide

CAS : 1187586-58-8

Couleur et forme : Neat

Ref: 86-MM0698.12

Montelukast EP Impurity E

CAS : 1187586-58-8

Formule : C₄₁H₄₆ClNO₅S₂

Masse moléculaire : 732.39

Ref: ST-EA-CP-M25005

(R,S)-Montelukast Bis-sulfide (>90%)

Produit contrôlé

CAS : 1187586-58-8

Impurity Montelukast EP Impurity E; Montelukast USP Related Compound D
Applications (R,S)-Montelukast Bis-sulfide (Montelukast EP Impurity E; Montelukast USP Related Compound D) is an impurity of Montelukast and is a part of the diastereomer mixture Montelukast Bis-Sulfide (M567985).

Formule : C₄₁H₄₆ClNO₅S₂

Couleur et forme : Neat

Masse moléculaire : 732.39

Ref: TR-M567975

(R,S)-Montelukast bis-sulfide

CAS : 1187586-58-8

(R,S)-Montelukast bis-sulfide is an analog of Montelukast, which is a leukotriene receptor antagonist used to treat asthma and allergic rhinitis. This compound has shown potential as a cancer cell inhibitor due to its ability to induce apoptosis in various types of cancer cells. It acts as a protein kinase inhibitor, specifically targeting cyclin-dependent kinases (CDKs), which are involved in cell cycle regulation and are often overexpressed in tumors. (R,S)-Montelukast bis-sulfide has been shown to inhibit the growth of human cancer cells and induce apoptosis in Chinese hamster ovary cells. It has also demonstrated anticancer activity by inhibiting tumor formation in mice. This compound can be detected in urine, making it a promising candidate for future cancer therapies.

Formule : C₄₁H₄₆ClNO₅S₂

Degré de pureté : Min. 95%

Masse moléculaire : 732.4 g/mol

Ref: 3D-MXB58658